ReviewCurrent psychiatry reports2025
Prevalence of Self-Reported Diagnoses of Attention-Deficit/Hyperactivity Disorder (ADHD) among Post-secondary Students in the U.S.: A Narrative Review.
Review in Current psychiatry reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewTo investigate the prevalence of self-reported diagnoses of ADHD among U.S. post-secondary students. RECENT
findingsWe identified fifteen empirical studies published in academic journals between 2008 and 2023 that reported ADHD prevalence estimates. These studies had variability in samples and methods and produced a wide range of prevalence estimates-3.4% to 11.2%-and an overall prevalence estimate of 9.1%. We supplemented the academic literature with data from two multi-institutional, annual surveys-the Healthy Minds Study and National College Health Assessment (NCHA III/IIIb). Their prevalence estimates for the 2024-2025 academic year were 14% and 15%, respectively, which reflected significant increases from their 2019-2020 estimates of 4% and 8%. Estimates for the prevalence of ADHD diagnoses vary by data source and method. Multi-institutional, annual surveys suggest an increase in prevalence in recent years. These data might warrant the strengthening of ADHD services provided by campus clinics.
Indexed as
Identifiers
41389141What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.